Publications (39) Publications in which a researcher has participated View referenced research data.

in the year 2019 Remove filter
filter_list from 2019 to 2019

2019

  1. A Bioreactor Technology for Modeling Fibrosis in Human and Rodent Precision-Cut Liver Slices

    Hepatology, Vol. 70, Núm. 4, pp. 1377-1391

  2. A novel human Cdh1 mutation impairs anaphase promoting complex/cyclosome activity resulting in microcephaly, psychomotor retardation, and epilepsy

    Journal of Neurochemistry, Vol. 151, Núm. 1, pp. 103-115

  3. Abstract C088: Chemical phosphoproteomics systematically identifies circuitries of kinase networks in cancer cells and predicts their response to kinase inhibitors

    Molecular Cancer Therapeutics, Vol. 18, Núm. 12_Supplement, pp. C088-C088

  4. Amyloid-ß promotes neurotoxicity by Cdk5-induced p53 stabilization

    Neuropharmacology, Vol. 146, pp. 19-27

  5. Astrocytic mitochondrial ROS modulate brain metabolism and mouse behaviour

    Nature Metabolism

  6. Biopiracy versus One-World Medicine–From colonial relicts to global collaborative concepts

    Phytomedicine, Vol. 53, pp. 319-331

  7. Cardiotrophin-1 opposes renal fibrosis in mice: Potential prevention of chronic kidney disease

    Acta Physiologica, Vol. 226, Núm. 2

  8. Cdc14 activation requires coordinated Cdk1-dependent phosphorylation of Net1 and PP2A–Cdc55 at anaphase onset

    Cellular and Molecular Life Sciences, Vol. 76, Núm. 18, pp. 3601-3620

  9. Central role of cell cycle regulation in the antitumoral action of ocoxin

    Nutrients, Vol. 11, Núm. 5

  10. Concomitant deletion of HRAS and NRAS leads to pulmonary immaturity, respiratory failure and neonatal death in mice

    Cell Death and Disease, Vol. 10, Núm. 11

  11. Connexins in cancer: bridging the gap to the clinic

    Oncogene, Vol. 38, Núm. 23, pp. 4429-4451

  12. Deferasirox reduces oxidative DNA damage in bone marrow cells from myelodysplastic patients and improves their differentiation capacity

    British Journal of Haematology, Vol. 187, Núm. 1, pp. 93-104

  13. Does APC/CCDH1 control the human brain size?: An Editorial Highlight for ‘A novel human Cdh1 mutation impairs anaphase-promoting complex/cyclosome (APC/C) activity resulting in microcephaly, psychomotor retardation, and epilepsy’ on page 103

    Journal of Neurochemistry, Vol. 151, Núm. 1, pp. 8-10

  14. Epigenetic events involved in organic cation transporter 1-dependent impaired response of hepatocellular carcinoma to sorafenib

    British Journal of Pharmacology, Vol. 176, Núm. 6, pp. 787-800

  15. Essentiality of fatty acid synthase in the 2D to anchorage-independent growth transition in transforming cells

    Nature Communications, Vol. 10, Núm. 1

  16. Exploring target genes involved in the effect of quercetin on the response to oxidative stress in caenorhabditis elegans

    Antioxidants, Vol. 8, Núm. 12

  17. Farmacogenómica: la medicina personalizada

    Revista del laboratorio clínico, Vol. 12, Núm. 3, pp. 147-154

  18. Fatty acids and antioxidants in multiple sclerosis: Therapeutic role of GEMSP

    Current Pharmaceutical Design, Vol. 25, Núm. 4, pp. 376-380

  19. Fibrogenic Activity of MECP2 Is Regulated by Phosphorylation in Hepatic Stellate Cells

    Gastroenterology, Vol. 157, Núm. 5, pp. 1398-1412.e9

  20. Male reproductive dysfunction in Solea senegalensis: New insights into an unsolved question

    Reproduction, Fertility and Development, Vol. 31, Núm. 6, pp. 1104-1115